Effect of Helper Lipids on Stability and Transfection Activity of Lyophilized Lipoplex Formulations of Antisense and DOTAP Nanoliposomes Stability and transfection activity of lyophilized lipoplex formulations
Iranian Journal of Pharmaceutical Sciences,
Vol. 7 No. 2 (2011),
1 Farvardin 2011
,
Page 79-87
https://doi.org/10.22037/ijps.v7.41327
Abstract
Survivin, an inhibitor of apoptosis protein is highly expressed in most cancers and considered as an attractive target for cancer antisense therapy. To vectorize antisense molecules, cationic nanoliposomes are generally used; however, their complexes are too instable, during shelf-life and upon exposure to blood components and extracellular matrix, to be used in-vivo. The present study aimed to develop fresh and lyophilized formulations of antisense/DOTAP nanoliposomes with different helper lipids and compare their shelflife and biologic stabilities and their transfection activities in tumor cell lines. DOTAP nanoliposomes in combination with different helper lipids were prepared in HEPES buffer (20 mM, pH=7.4) by thin-layer hydration followed by thermobarrel extrusion and PTFE membrane filter sterilization. Nanoliposomes were characterized regarding their particle size distribution, final lipid recovery and physical stability. Following antisense loading by direct addition through electrostatic attraction, the degree of complexation was determined by ethidium bromide displacement assay. To stabilize the formulations, they were freezedried with 10% sucrose. The potential of the lyophilized and fresh formulations of
FITC-labeled antisense to transfect different cell lines (SK-BR-3, MCF-7) was studied by flow cytometry. Fresh nanoliposomes of different formulations had a size in range of 50-100 nm. The degree of complex formation with antisense was determined almost 70-80% (N/P ~ 2) which decreased as incubated with either PBS or complete medium and heparin sulfate. Their average sizes significantly changed after preservation for few days at 4 °C.Lyophilization process compromised the particle size distribution and antisense loading efficiency of different formulations except for DOTAP/DOPE (1:1 mole ratio) which did
not change significantly. Both fresh and lyophilized formulations exhibited the highest transfection activity at comparable levels especially in SK-BR-3 cells. As a conclusion, lyophilization process could promote stability and preserve transfection activity of the antisense complexes of DOTAP/DOPE (1:1) nanoliposomes.
- DOTAP nanoliposome;
- Lyophilization;
- Stability;
- Survivin antisense;
- Transfection activity.
How to Cite
References
[2] Pennati M, Folini M, and Zaffaroni N. Targeting survivin in cancer therapy: fulfilled promises ad open questions. Carcinogenesis 2007; 28: 1133-9.
[3] Fukuda S, Pelus M. Survivin, a cancer target with emerging role in normal adult tissues. Mol Cancer Ther 2006; 5: 1087-98.
[4] El- Aneed A. An overview of current delivery systems in cancer gene therapy. J Control Release 2004; 94: 1-14.
[5] Patil SD, Rhodes DG, Burgess DJ. DNA- based therapeutics and DNA delivery systems: a comprehensive review. Am Associat Pharm Sci J 2005; 7: 61-77.
[6] Hart SL. Lipid carriers for gene therapy. Curr Drug Deliv 2005; 2: 423-8.
[7] Zhdanov RI, Podobed OV, Vlassov W. Catinic lipid-DNA complexes-lipoplexes-for gene transfer and therapy. Bioelectrochemistry 2002; 58: 53-64.
[8] Zhang S, Xu Y, Wang B, Qiao W, Liu D, Li Z. Cationic compounds used in lipoplexes and polyplexes for gene delivery. J Control Release 2004; 100: 165-80.
[9] Hinrichs WLJ, Mance˜nido FA, Sanders NN, Braeckmans K, De Smedt SC, Demeester J, Frijlink HW. The choice of a suitable oligosaccharide to prevent aggregation of PEGylated nanoparticles during freeze thawing and freeze drying. Int J Pharm 2006; 311: 237-44.
[10] Yadava P, Gibbs M, Castro C. Effect of lyophilization and freeze-thawing on the stability of siRNA- liposome complexes. AAPS Pharm Sci Tech 2008; 9: 335-41.
[11] van Winden EC. Freeze-drying of liposomes: theory and practice. Methods Enzymol 2003; 367:99-110.
[12] Tamaddon AM, Shiraz FH, Moghimi HR. Preparation of oligonucleotides encapsulated cationic liposomes and release study with models of cellular membranes. Daru 2007; 15: 61-70.
[13] Geall AJ, Blaghbrough IS. Rapid and sensitive ethidium bromide fluorescence quenching assay of polyamino conjugate-DNA ineractions for the analysis of lipoplex formation in gene therapy. J Pharm Biomed Anal 2000; 22: 849-59.
[14] Tamaddon AM, Shiraz FH, Moghimi HR. Modeling cytoplasmic release of encapsulated oligonucleotides from cationic liposomes. Int J Pharm 2007; 336: 174-82.
[15] Maruyama K. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Adv Drug Deliv Rev 2011; 63: 161-9.
[16] Hinrichs WLJ, Sandersb NN, De Smedt SC, Demeesterb J, Frijlink HW. Inulin is a promising cryo- and lyo-protectant for PEGylated lipoplexes. J Control Release 2005; 103: 465-79.
[17] Aso Y, Yoshioka S. Effect of freezing rate on physical stability of lyophilized cationic liposomes. Chem Pharm Bull 2005; 53: 301-4.
[18] Cortesi R, Esposito E, Nastruzzi C. Effect of DNA complexation and freeze-drying on the physicochemical characteristics of cationic liposomes. Antisense Nucleic Acid Drug Dev 2000; 10: 205-15.
[19] Maitani Y, Asob Y, Yamada A, Yoshioka S. Effect of sugars on storage stability of lyophilized liposome/DNA complexes with high transfection efficiency. Int J Pharm 2008; 356: 69-75.
- Abstract Viewed: 78 times
- IJPS_Volume 7_Issue 2_Pages 79-87 Downloaded: 31 times